Canton Strategic Holdings, Inc.

CNTN

Healthcare

$3.22-0.41%vs prev close

$1.08

$9.08

52W Range

+0.07 (+2.24%)Past 1M

Price

Stock Timeline

Institutional Holders

1 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest

LIVE

443,051

Portfolio Weight

0.01%

in ETF 0.16%

Est. Value

$1M

30D Net

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

No analyst data available

Price Information

Previous Close$3.23

Open$3.20

Day Range$3.13 - $3.25

52-Week Range$1.08 - $9.08

1-Year Change109.74%

Trading Volume

Volume311,504

Avg Volume (3mo)615,086

Valuation

Market Cap182.2M

Book Value$10.72

Shares Outstanding56,656,271

Financials

Revenue (TTM)-

Net Income-35,916,248

EPS$-1.12

EBITDA-

Profitability

P/E Ratio-

P/B Ratio0.30

Return on Equity (ROE)-17.99%

Return on Assets (ROA)-4.81%

Profit Margin0.00%

EV/EBITDA-

Beta1.46

Dividend

Dividend Rate-

Dividend Yield-

Technical

RSI(14)39.75

Company Overview

Canton Strategic Holdings, Inc. is focused on advancing institutional blockchain adoption and financial market digitization through its Canton Coin and network. The company is also developing innovative pharmaceutical technologies, including GV104 for respiratory/nervous system depression and GV023, an oral formulation of infliximab, aiming to improve treatment accessibility and reduce burden.

P/B

0.30

Below book value

ROE

-18.0%

Net loss

Beta

1.46

Market Volatility

RSI(14)

39.8

Neutral zone

AI-generated summary. Not investment advice.